About 1910 Genetics
1910 Genetics is a biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. The company integrates AI with three proprietary data streams — computational data, wet lab proxy biological data, and wet lab ground truth biological data — to deliver novel drug candidates and software solutions to pharma and tech partners. It also advances an internal pipeline targeting neurological, autoimmune diseases, and cancer.
Company details
Funding
Total raised
$29.8M
Last stage
Series A
Investors
Founders
Jen Nwankwo
PhD-holding founder and CEO of 1910 Genetics, leading the company's AI-driven drug discovery platform since its founding in 2018.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.